Takeda's academic alliance aims to accelerate nanoparticle vaccine research
This article was originally published in Scrip
Executive Summary
Takeda's support of a new joint research chair at Osaka University in Japan is designed to progress research into vaccines containing novel nanoparticle adjuvants, which hold out the promise of improved safety and immunogenic response.